
C5-6 B-problem
disc I-problem
herniation I-problem
with O
cord B-problem
compression I-problem
and O
myelopathy B-problem
. O


Microscopic B-treatment
anterior I-treatment
cervical I-treatment
diskectomy I-treatment
at I-treatment
C5-6 I-treatment
and O
fusion B-treatment
. O


The O
patient O
is O
a O
63-year-old O
female O
with O
a O
three-year O
history O
of O
bilateral B-problem
hand I-problem
numbness I-problem
and O
occasional B-problem
weakness I-problem
. O


Within O
the O
past O
year O
, O
these B-problem
symptoms I-problem
have O
progressively O
gotten O
worse O
, O
to O
encompass O
also O
her O
feet O
. O


She O
had O
a B-test
workup I-test
by O
her O
neurologist O
and O
an B-test
MRI I-test
revealed O
a B-problem
C5-6 I-problem
disc I-problem
herniation I-problem
with O
cord B-problem
compression I-problem
and O
a B-problem
T2 I-problem
signal I-problem
change I-problem
at O
that O
level O
. O


Significant O
for O
hypertension B-problem
, O
hyperlipidemia B-problem
. O


Lipitor B-treatment
, O
Flexeril B-treatment
, O
hydrochlorothiazide B-treatment
and O
Norvasc B-treatment
. O


She O
has O
no O
known B-problem
drug I-problem
allergy I-problem
. O


She O
had O
a B-test
Hoffman I-test
&apos;s I-test
sign I-test
greater O
on O
the O
right O
than O
the O
left O
and O
she O
had O
10 B-problem
beats I-problem
of I-problem
clonus I-problem
in O
the O
right O
foot O
and O
3-5 B-problem
beats I-problem
in I-problem
the I-problem
left I-problem
foot I-problem
. O


She O
had O
hyperreflexia B-problem
in O
both O
the O
bilateral O
upper O
and O
lower O
extremities O
. O


The O
patient O
tolerated O
a B-treatment
C5-6 I-treatment
ACDF I-treatment
by O
Dr. O
Miezetri O
Gach O
quite O
well O
. O


She O
had O
a B-test
postoperative I-test
CT I-test
scan I-test
that O
revealed O
partial B-problem
decompression I-problem
of I-problem
the I-problem
spinal I-problem
canal I-problem
and O
good O
placement O
of O
her B-treatment
hardware I-treatment
. O


Immediately O
postop O
, O
her B-test
exam I-test
only O
improved O
slightly O
in O
her B-problem
hyperreflexia I-problem
. O


Her B-problem
pain I-problem
was O
under O
good O
control O
with O
PO B-treatment
pain I-treatment
medications I-treatment
and O
she O
was O
deemed O
suitable O
for O
discharge O
. O


The O
patient O
was O
asked O
to O
call O
Dr. O
Miezetri O
Gach O
&apos;s O
office O
for O
a O
follow-up O
appointment O
and O
wound B-test
check I-test
. O


She O
is O
asked O
to O
call O
with O
any O
fevers B-problem
, O
chills B-problem
, O
increasing B-problem
weakness I-problem
or O
numbness B-problem
or O
any O
bowel B-problem
and I-problem
bladder I-problem
disruption I-problem
. O


1. O
Colace B-treatment
, O
100 O
mg O
PO O
bid O
. O


2. O
Zantac B-treatment
, O
150 O
mg O
PO O
bid O
. O


3. O
Percocet B-treatment
, O
5/325 O
, O
1-2 O
tabs O
PO O
q4-6h O
prn O
pain B-problem
. O


4. O
Lipitor B-treatment
, O
10 O
mg O
PO O
daily O
. O


5. O
Hydrochlorothiazide B-treatment
, O
25 O
mg O
PO O
daily O
. O


6. O
Norvasc B-treatment
, O
5 O
mg O
PO O
daily O
. O
L B-problem
SHOULDER I-problem
INJ I-problem


The O
patient O
was O
given O
printed O
instructions O
for O
neck B-problem
strains I-problem
( O
English O
) O
. O


Left B-problem
Shoulder I-problem
/ I-problem
Neck I-problem
strain I-problem
/ I-problem
sprain I-problem
. O


Dilaudid B-treatment
2mg O
PO O
x O
1 O
Flexeril B-treatment
10 O
mg O
x O
1 O


Flexeril B-treatment
10mg O
TID O


Take O
codeine B-treatment
prescribed O
by O
PCP O
with O
food O
and O
water O
to O
prevent O
nausea B-problem
and O
constipation B-problem
. O


Do O
not O
drive O
if O
taking O
flexeril B-treatment
and O
codeine B-treatment
. O
NEAR B-problem
SYNCOPE I-problem
Standardized O
Discharge O
Instructions O
: O


The O
patient O
was O
given O
printed O
instructions O
for O
dizziness B-problem
( O
English O
) O
. O


near B-problem
syncope I-problem
, O
dehydration B-problem
vs O
cardiogenic B-problem


IVF B-treatment
, O
cbc B-test
( O
hct B-test
36 O
) O
, O
normal O
chem O
7 O
, O
negative O
cardiac O
enzymes O
, O
negative O
stool O
guaiac O
, O
normal O
CXR O


Dr. O
Foutchner O
will O
arrange O
for O
an B-test
outpatient I-test
Holter I-test
monitor I-test
. O


The O
patient O
is O
to O
return O
to O
the O
ED O
for O
recurrent B-problem
dizziness I-problem
, O
chest B-problem
pain I-problem
, O
shortness B-problem
of I-problem
breath I-problem
or O
weakness B-problem
. O
COPD B-problem
flare I-problem


ACETYLSALICYLIC B-treatment
ACID I-treatment
81 O
MG O
PO O
DAILY O
ALBUTEROL B-treatment
NEBULIZER I-treatment
2.5 O
MG O
NEB O
Q4H O
Starting O
Today O
( O
03/17 O
) O
PRN O
Shortness B-problem
of I-problem
Breath I-problem
LISINOPRIL B-treatment
10 O
MG O
PO O
DAILY O
NIFEREX-150 B-treatment
150 O
MG O
PO O
BID O
PREDNISONE B-treatment
Taper I-treatment
PO I-treatment
Give O
50 O
mg O
q O
24 O
h O
X O
1 O
dose O
( O
s O
) O
, O
then O
Give O
40 O
mg O
q O
24 O
h O
X O
1 O
dose O
( O
s O
) O
, O
then O
Give O
30 O
mg O
q O
24 O
h O
X O
1 O
dose O
( O
s O
) O
, O
then O
Give O
20 O
mg O
q O
24 O
h O
X O
1 O
dose O
( O
s O
) O
, O
then O
Give O
10 O
mg O
q O
24 O
h O
X O
1 O
dose O
( O
s O
) O
, O
then O
Starting O
Today O
( O
03/17 O
) O
CLARITIN B-treatment
( I-treatment
LORATADINE I-treatment
) I-treatment
10 O
MG O
PO O
DAILY O


Give O
on O
an O
empty O
stomach O
( O
give O
1hr O
before O
or O
2hr O
after O
food O
) O
SINGULAIR B-treatment
( I-treatment
MONTELUKAST I-treatment
) I-treatment
10 O
MG O
PO O
BEDTIME O
ADVAIR B-treatment
DISKUS I-treatment
500/50 I-treatment
( I-treatment
FLUTICASONE I-treatment
PROPIONATE/... I-treatment
) I-treatment
1 O
PUFF O
INH O
BID O
CALTRATE B-treatment
+ I-treatment
D I-treatment
1 O
TAB O
PO O
BID O
LANTUS B-treatment
( I-treatment
INSULIN I-treatment
GLARGINE I-treatment
) I-treatment
35 O
UNITS O
SC O
QAM O
DUONEB B-treatment
( I-treatment
ALBUTEROL I-treatment
AND I-treatment
IPRATROPIUM I-treatment
NEBULIZER I-treatment
) I-treatment
3/0.5 O
MG O
NEB O
Q6H O
Starting O
Today O
( O
03/17 O
) O
PRN O
Shortness B-problem
of I-problem
Breath I-problem
, O
Wheezing B-problem
NOVOLOG B-treatment
( I-treatment
INSULIN I-treatment
ASPART I-treatment
) I-treatment
4 O
UNITS O
SC O
AC O


standing B-treatment
pre-meal I-treatment
novolog I-treatment
. O


NOVOLOG B-treatment
( I-treatment
INSULIN I-treatment
ASPART I-treatment
) I-treatment
Sliding O
Scale O
( O
subcutaneously O
) O
SC O
AC O


give O
in O
addition O
to O
standing B-treatment
pre-meal I-treatment
novolog I-treatment
when O
patient O
will O
eat O
and O
food O
is O
in O
the O
room O
. O


If O
BS B-test
is O
less O
than O
125 O
, O
then O
give O
0 O
units O
subcutaneously O
If O
BS B-test
is O
125-150 O
, O
then O
give O
2 O
units O
subcutaneously O
If O
BS B-test
is O
151-200 O
, O
then O
give O
3 O
units O
subcutaneously O
If O
BS B-test
is O
201-250 O
, O
then O
give O
4 O
units O
subcutaneously O
If O
BS B-test
is O
251-300 O
, O
then O
give O
6 O
units O
subcutaneously O
If O
BS B-test
is O
301-350 O
, O
then O
give O
8 O
units O
subcutaneously O
If O
BS B-test
is O
351-400 O
, O
then O
give O
10 O
units O
subcutaneously O
and O
call O
HO O
Call O
HO O
if O
BS B-test
is O
greater O
than O
400 O
PROTONIX B-treatment
( I-treatment
PANTOPRAZOLE I-treatment
) I-treatment
40 O
MG O
PO O
DAILY O
COMBIVENT B-treatment
( I-treatment
IPRATROPIUM I-treatment
AND I-treatment
ALBUTEROL I-treatment
SULFATE I-treatment
) I-treatment
2 O
PUFF O
INH O
QID O
FOSAMAX B-treatment
( I-treatment
ALENDRONATE I-treatment
) I-treatment
70 O
MG O
PO O
QWEEK O


Take O
with O
8 O
oz O
of O
plain O
water O
SPIRIVA B-treatment
( I-treatment
TIOTROPIUM I-treatment
) I-treatment
18 O


walk O
with O
assist O
per O
PT B-test
eval I-test


COPD B-problem
flare I-problem


Responsible O
After O
Study O
for O
Causing O
Admission O
) O
COPD B-problem
flare I-problem


COPD B-problem
( I-problem
chronic I-problem
obstructive I-problem
pulmonary I-problem
disease I-problem
) I-problem
DM B-problem
cervical B-problem
DJD I-problem
( O
) O
iron B-problem
deficiency I-problem
anemia I-problem
( I-problem
iron I-problem
deficiency I-problem
anemia I-problem
) I-problem
cervical B-problem
and I-problem
lumbar I-problem
djd I-problem
( O
12 O
) O
osa B-problem
( I-problem
sleep I-problem
apnea I-problem
) I-problem
s O
/ O
p O
tb B-treatment
treatment I-treatment
( O
5 O
) O


weakness B-problem


75 O
y O
/ O
o O
F O
with O
DM B-problem
, O
COPD B-problem
on O
2L B-treatment
NC I-treatment
and O
Bipap B-treatment
at O
night O
p O
/ O
w O
generalized B-problem
weakness I-problem
and O
fatigue B-problem
, O
urinary B-problem
incontinence I-problem
and O
shaking B-problem
as O
well O
as O
increased B-problem
sputum I-problem
production I-problem
. O


Per O
daughter O
these B-problem
symptoms I-problem
are O
typical O
of O
COPD B-problem
flare I-problem
. O


REc&apos;d O
duonebs B-treatment
, O
solumedrol B-treatment
125 O


t97.5 O
, O
hr B-test
117 O
, O
bp156/81 O
, O
rr28 O
, O
o2 B-test
sats I-test
87% O
RA O
; O
95% O
4L O


NAD B-problem
, O
pleasant O
, O
speaking O
in O
complete O
sentences O
, O
poor B-problem
air I-problem
movement I-problem
bilaterally I-problem
, O
L O
&gt; O
R O
, O
no O
wheezes B-problem
or O
rales B-problem
, O
rrr O
, O
distant O
, O
abd O
benign O
, O
no O
edema B-problem
, O
alert O
and O
oriented O
times O
three O
, O
no O
focal B-problem
deficits I-problem
, O
conversant O
Studies O
: O